GSA Capital Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$504K Buy
+6,556
New +$512K 0.03% 914
2024
Q3
Sell
-11,802
Closed -$752K 1574
2024
Q2
$752K Buy
+11,802
New +$766K 0.05% 709
2024
Q1
Sell
-9,355
Closed -$516K 1581
2023
Q4
$516K Buy
+9,355
New +$515K 0.04% 774
2022
Q2
Sell
-8,920
Closed -$251K 1374
2022
Q1
$251K Buy
+8,920
New +$333K 0.03% 1028
2021
Q4
Sell
-26,345
Closed -$865K 1394
2021
Q3
$865K Buy
26,345
+6,809
+35% +$212K 0.09% 376
2021
Q2
$685K Buy
+19,536
New +$665K 0.08% 432
2020
Q3
Sell
-8,115
Closed -$262K 1232
2020
Q2
$262K Buy
8,115
+2,485
+44% +$89.1K 0.15% 225
2020
Q1
$229K Sell
5,630
-93
-2% -$4.95K 0.06% 667
2019
Q4
$353K Sell
5,723
-3,576
-38% -$237K 0.04% 899
2019
Q3
$678K Sell
9,299
-15,849
-63% -$1.19M 0.09% 353
2019
Q2
$2.07M Buy
25,148
+1,353
+6% +$96.2K 0.23% 37
2019
Q1
$1.68M Sell
23,795
-5,805
-20% -$342K 0.17% 98
2018
Q4
$1.33M Buy
29,600
+4,100
+16% +$215K 0.15% 125
2018
Q3
$1.44M Sell
25,500
-100
-0.4% -$6.12K 0.08% 446
2018
Q2
$1.71M Buy
25,600
+18,500
+261% +$1.15M 0.08% 360
2018
Q1
$413K Sell
7,100
-800
-10% -$50.8K 0.02% 1158
2017
Q4
$509K Sell
7,900
-2,200
-22% -$137K 0.03% 927
2017
Q3
$530K Buy
+10,100
New +$482K 0.04% 933
2017
Q2
Sell
-58,310
Closed -$2.89M 1654
2017
Q1
$2.89M Buy
58,310
+4,556
+8% +$256K 0.15% 114
2016
Q4
$3.26M Sell
53,754
-1,056
-2% -$64.6K 0.19% 57
2016
Q3
$3.64M Sell
54,810
-14,900
-21% -$932K 0.2% 63
2016
Q2
$3.89M Buy
69,710
+3,364
+5% +$164K 0.22% 39
2016
Q1
$2.23M Buy
66,346
+10,899
+20% +$370K 0.14% 145
2015
Q4
$2.5M Buy
55,447
+5,420
+11% +$233K 0.12% 180
2015
Q3
$1.98M Buy
50,027
+22,825
+84% +$1.3M 0.1% 268
2015
Q2
$1.69M Sell
27,202
-18,525
-41% -$1.1M 0.06% 507
2015
Q1
$2.86M Sell
45,727
-27
-0.1% -$1.64K 0.11% 179
2014
Q4
$2.58M Sell
45,754
-3,600
-7% -$159K 0.18% 82
2014
Q3
$1.4M Buy
49,354
+19,300
+64% +$578K 0.07% 329
2014
Q2
$1.03M Buy
+30,054
New +$942K 0.05% 657

Other funds holding ANIP